Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Archrock
AROC
$5.8B
| $2.49M | ﹤0.01% |
277,420
-74,721
| -21% | -$598K |
|
|
NXDR
3702
Nextdoor Holdings
NXDR
$986M
| $2.49M | ﹤0.01% |
1,208,152
+59,881
| +5% | +$140K |
|
3703
Alamo Group
ALG
$2.05B
| $2.48M | ﹤0.01% |
17,546
-37,292
| -68% | -$5.4M |
|
3704
Bally's
BALY
$658M
| $2.48M | ﹤0.01% |
128,146
-369,380
| -74% | -$8.11M |
|
|
CSLM
3705
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
| $2.48M | ﹤0.01% |
245,000
| – | – |
|
3706
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $2.48M | ﹤0.01% |
+55,212
| New | +$2.42M |
|
3707
Radware
RDWR
$1.19B
| $2.48M | ﹤0.01% |
125,495
+20,238
| +19% | +$423K |
|
3708
CALL
Teladoc Health
TDOC
$1.3B
| $2.48M | ﹤0.01% |
104,700
| – | – |
|
3709
Immunocore
IMCR
$1.73B
| $2.47M | ﹤0.01% |
+43,343
| New | +$2.44M |
|
3710
CALL
iShares MSCI Germany ETF
EWG
$1.62B
| $2.47M | ﹤0.01% |
100,000
-470,500
| -82% | -$11M |
|
3711
CALL
Zscaler
ZS
$27.3B
| $2.47M | ﹤0.01% |
22,100
| – | – |
|
3712
Scholar Rock
SRRK
$6.44B
| $2.47M | ﹤0.01% |
272,589
-150,848
| -36% | -$1.21M |
|
3713
Xtrackers S&P 500 ESG ETF
SNPE
$2.75B
| $2.46M | ﹤0.01% |
71,263
+17,283
| +32% | +$601K |
|
|
IAS
3714
DELISTED
Integral Ad Science
IAS
| $2.46M | ﹤0.01% |
279,884
+106,707
| +62% | +$905K |
|
|
SRNE
3715
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.46M | ﹤0.01% |
2,773,811
-236,329
| -8% | -$313K |
|
3716
Lazard
LAZ
$4.31B
| $2.46M | ﹤0.01% |
70,821
+5,677
| +9% | +$202K |
|
3717
Zeta Global
ZETA
$6.69B
| $2.45M | ﹤0.01% |
300,304
-75,049
| -20% | -$608K |
|
3718
Nektar Therapeutics
NKTR
$2.58B
| $2.45M | ﹤0.01% |
72,266
-1,242
| -2% | -$60.1K |
|
3719
WisdomTree US High Dividend Fund
DHS
$1.58B
| $2.45M | ﹤0.01% |
+28,459
| New | +$2.41M |
|
3720
Ternium
TX
$10.6B
| $2.45M | ﹤0.01% |
80,084
+59,752
| +294% | +$1.79M |
|
|
ILPT
3721
Industrial Logistics Properties Trust
ILPT
$586M
| $2.45M | ﹤0.01% |
748,401
-41,768
| -5% | -$174K |
|
3722
Global Net Lease
GNL
$1.95B
| $2.44M | ﹤0.01% |
194,460
-21,470
| -10% | -$266K |
|
3723
Crinetics Pharmaceuticals
CRNX
$8.92B
| $2.44M | ﹤0.01% |
133,316
+10,648
| +9% | +$188K |
|
3724
PUT
Ulta Beauty
ULTA
$24.3B
| $2.44M | ﹤0.01% |
5,200
-2,200
| -30% | -$949K |
|
3725
PUT
Beyond Meat
BYND
$277M
| $2.44M | ﹤0.01% |
198,100
-725,000
| -79% | -$10.1M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.